메뉴 건너뛰기




Volumn 14, Issue 6, 1996, Pages 354-359

The role of paclitaxel in chemosensitive urological malignancies: Current strategies in bladder cancer and testicular germ-cell tumors

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL;

EID: 0030341774     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00183114     Document Type: Article
Times cited : (19)

References (37)
  • 2
    • 0028033791 scopus 로고
    • Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer
    • Bokemeyer C, Schmoll HJ, Natt F, Knoche M, Beyer J, Souchon R (1994) Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. J Cancer Res Clin Oncol 120:754-757
    • (1994) J Cancer Res Clin Oncol , vol.120 , pp. 754-757
    • Bokemeyer, C.1    Schmoll, H.J.2    Natt, F.3    Knoche, M.4    Beyer, J.5    Souchon, R.6
  • 4
    • 0026023964 scopus 로고
    • Enhanced host cell reactivation of damaged plasmid DNA in HeLA cells resistant to r/s-diamminedichloroplatinum(II)
    • Chao CCK, Lee YL, Cheng PW, Chao SL (1991) Enhanced host cell reactivation of damaged plasmid DNA in HeLA cells resistant to r/s-diamminedichloroplatinum(II). Cancer Res 51 : 601-605
    • (1991) Cancer Res , vol.51 , pp. 601-605
    • Cck, C.1    Lee, Y.L.2    Cheng, P.W.3    Chao, S.L.4
  • 5
    • 0028153260 scopus 로고
    • Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: A rational approach to clinical protocol design
    • Chou TC, Motzer RJ, Tong Y, Bosl GJ (1994) Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design. J Natl Cancer Inst 86:1517-1524
    • (1994) J Natl Cancer Inst , vol.86 , pp. 1517-1524
    • Chou, T.C.1    Motzer, R.J.2    Tong, Y.3    Bosl, G.J.4
  • 8
    • 0141493747 scopus 로고    scopus 로고
    • Paclitaxel in advanced urothelial carcinoma: Its role in patients with renal insufficiency and as salvage therapy (abstract 607)
    • Dreicer R, Gustin D, See WA, Williams RD (1996) Paclitaxel in advanced urothelial carcinoma: its role in patients with renal insufficiency and as salvage therapy (abstract 607). Proc Am Soc Clin Oncol 15:242
    • (1996) Proc Am Soc Clin Oncol , vol.15 , pp. 242
    • Dreicer, R.1    Gustin, D.2    See, W.A.3    Williams, R.D.4
  • 9
    • 0025152039 scopus 로고
    • Treatment of testicular cancer: A new and improved model
    • Einhorn LH (1990) Treatment of testicular cancer: a new and improved model. J Clin Oncol 8:1777-1781
    • (1990) J Clin Oncol , vol.8 , pp. 1777-1781
    • Einhorn, L.H.1
  • 10
    • 0023945042 scopus 로고
    • Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium
    • Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MA, Clarkson B et al. (1988) Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318:1414-1422
    • (1988) N Engl J Med , vol.318 , pp. 1414-1422
    • Gabrilove, J.L.1    Jakubowski, A.2    Scher, H.3    Sternberg, C.4    Wong, G.5    Grous, J.6    Yagoda, A.7    Fain, K.8    Ma, M.9
  • 11
    • 0022360630 scopus 로고
    • Cisplatin, methotrexate, and vinblastine (CMV): An effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract: a Northern California Oncology Group study
    • Harker WG, Meyers JF, Freiha FS, Palmer JM, Shortliffe LD, Hannigan JF, McWhirter KM, Torti FM (1985) Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract: a Northern California Oncology Group study. J Clin Oncol 3:1463-1470
    • (1985) J Clin Oncol , vol.3 , pp. 1463-1470
    • Harker, W.G.1    Meyers, J.F.2    Freiha, F.S.3    Palmer, J.M.4    Shortliffe, L.D.5    Hannigan, J.F.6    McWhirter, K.M.7    Torti, F.M.8
  • 12
    • 0028209409 scopus 로고
    • Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer
    • Herr HW, Scher HI (1994) Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. J Clin Oncol 12: 975-980
    • (1994) J Clin Oncol , vol.12 , pp. 975-980
    • Herr, H.W.1    Scher, H.I.2
  • 13
    • 13344282373 scopus 로고
    • Deficient removal of the major platinum-DNA intrastrand crosslinks in the sequences pGpG and pApG appears characteristic of testicular teratoma cell lines derived from tumours from untreated patients and may account for their sensitivity to cisplatin (abstract 221)
    • Hill BT, Shellard SA, Whelan RDH, Fera MF, Harstrick A, Fichtinger-Schepman AJ (1992) Deficient removal of the major platinum-DNA intrastrand crosslinks in the sequences pGpG and pApG appears characteristic of testicular teratoma cell lines derived from tumours from untreated patients and may account for their sensitivity to cisplatin (abstract 221). Proc Am Soc Oncol 11:100
    • (1992) Proc Am Soc Oncol , vol.11 , pp. 100
    • Hill, B.T.1    Shellard, S.A.2    Rdh, W.3    Fera, M.F.4    Harstrick, A.5    Fichtinger-Schepman, A.J.6
  • 17
    • 33747684724 scopus 로고    scopus 로고
    • A phase II trial of ifosfamide, paclitaxel and cisplatin (ITP) in patients (pts) with advanced urothelial tract tumors (abstract 641)
    • McCaffrcy J, Hilton S, Mazumdar M, Spicer J, Meegan G, Kelly K, Scher H, Bajorin D (1996) A phase II trial of ifosfamide, paclitaxel and cisplatin (ITP) in patients (pts) with advanced urothelial tract tumors (abstract 641). Proc Am Soc Clin Oncol 125:251
    • (1996) Proc Am Soc Clin Oncol , vol.125 , pp. 251
    • McCaffrcy, J.1    Hilton, S.2    Mazumdar, M.3    Spicer, J.4    Meegan, G.5    Kelly, K.6    Scher, H.7    Bajorin, D.8
  • 21
    • 0002575775 scopus 로고    scopus 로고
    • Phase II trial of paclitaxel (P) and cisplatin (C) for métastases of locally unresectable urothelial cancer (abstract 617)
    • Murphy BA, Johnson DR, Smith J, Koch M, DeVore R, Blanke C, Johnson DH (1996) Phase II trial of paclitaxel (P) and cisplatin (C) for métastases of locally unresectable urothelial cancer (abstract 617). Proc Am Soc Clin Oncol 15:245
    • (1996) Proc Am Soc Clin Oncol , vol.15 , pp. 245
    • Murphy, B.A.1    Johnson, D.R.2    Smith, J.3    Koch, M.4    Devore, R.5    Blanke, C.6    Johnson, D.H.7
  • 22
    • 0024338525 scopus 로고
    • Dose-intensive chemotherapy in refractory germ cell cancer: A phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation
    • Nichols C, Tricot G, Williams S, Besien K van, Loehrer PJ, Roth BJ, Akard L, Hoffman R, Goulet R. Wolff SN, et al. (1989) Dose-intensive chemotherapy in refractory germ cell cancer: a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol 7: 932-939
    • (1989) J Clin Oncol , vol.7 , pp. 932-939
    • Nichols, C.1    Tricot, G.2    Williams, S.3    Van Besien, K.4    Loehrer, P.J.5    Roth, B.J.6    Akard, L.7    Hoffman, R.8    Wolff Sn, G.R.9
  • 23
    • 0000917064 scopus 로고
    • The activity of antimicrotubular agents in human bladder tumor cell lines (abstract)
    • Niell HB, Rangel C, Miller A, Cox C (1993) The activity of antimicrotubular agents in human bladder tumor cell lines (abstract). Proc Am Assoc Cancer Res 34:202
    • (1993) Proc Am Assoc Cancer Res , vol.34 , pp. 202
    • Niell, H.B.1    Rangel, C.2    Miller, A.3    Cox, C.4
  • 24
    • 0001744685 scopus 로고    scopus 로고
    • Preliminary results of taxol/cisplatin chemotherapy in patients with refractory or relapsed nonseminomatous germ cell tumor (abstract 1161)
    • Partyka S, Hutchinson L, Amato R (1996) Preliminary results of taxol/cisplatin chemotherapy in patients with refractory or relapsed nonseminomatous germ cell tumor (abstract 1161). Proc Am Assoc Cancer Res 37: 169
    • (1996) Proc Am Assoc Cancer Res , vol.37 , pp. 169
    • Partyka, S.1    Hutchinson, L.2    Amato, R.3
  • 26
    • 0028938652 scopus 로고
    • Advanced bladder cancer: The need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world
    • Roth BJ, Bajorin DF (1995) Advanced bladder cancer: the need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world. J Urol 153:894-900
    • (1995) J Urol , vol.153 , pp. 894-900
    • Roth, B.J.1    Bajorin, D.F.2
  • 27
    • 0027999651 scopus 로고
    • Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: A phase II trial of the Eastern Cooperative Oncology Group
    • Roth B, Dreicer R, Einhorn LH, Neuber D, Johnson DH, Smith JL, Hudes GR, Schultz M, Loehrer PJ (1994) Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group. J Clin Oncol 12:2264-2270
    • (1994) J Clin Oncol , vol.12 , pp. 2264-2270
    • Roth, B.1    Dreicer, R.2    Einhorn, L.H.3    Neuber, D.4    Johnson, D.H.5    Smith, J.L.6    Hudes, G.R.7    Schultz, M.8    Loehrer, P.J.9
  • 30
    • 0026706878 scopus 로고
    • Chemotherapy for urothelial tract malignancies
    • Scher HI, Norton L (1992) Chemotherapy for urothelial tract malignancies. Semin Surg Oncol 8:316-341
    • (1992) Semin Surg Oncol , vol.8 , pp. 316-341
    • Scher, H.I.1    Norton, L.2
  • 31
    • 0027528981 scopus 로고
    • Effect of relative cumulative dose-intensity on survival of patients with urothelial cancer treated with M-VAC
    • Scher HI, Geller NL, Curley T, Tao Y ( 1993) Effect of relative cumulative dose-intensity on survival of patients with urothelial cancer treated with M-VAC. J Clin Oncol 11:400-407
    • (1993) J Clin Oncol , vol.11 , pp. 400-407
    • Scher, H.I.1    Geller, N.L.2    Curley, T.3    Tao, Y.4
  • 32
    • 0018387446 scopus 로고
    • Promotion of microtubule assembly in vitro by taxol
    • Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277:655-667
    • (1979) Nature , vol.277 , pp. 655-667
    • Schiff, P.B.1    Fant, J.2    Horwitz, S.B.3
  • 34
    • 0028229053 scopus 로고
    • High-dose treatment with carboplatin, etoposide and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: A phase I/II study
    • Siegert W, Beyer J, Strohscheer I, Baurmann H, Oettle H, Zingsem J, Zimmermann R, Bokemeyer C, Schmoll HJ, Huhn D (1994) High-dose treatment with carboplatin, etoposide and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. J Clin Oncol 12:1223-1231
    • (1994) J Clin Oncol , vol.12 , pp. 1223-1231
    • Siegert, W.1    Beyer, J.2    Strohscheer, I.3    Baurmann, H.4    Oettle, H.5    Zingsem, J.6    Zimmermann, R.7    Bokemeyer, C.8    Schmoll, H.J.9    Huhn, D.10
  • 35
    • 0024817806 scopus 로고
    • Methotrexate, vinblastine, doxorubicin and cisplatin for advanced transitional cell carcinoma of the urothelium: Efficacy and patterns of response and relapse
    • Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC. Vaughan ED, Bander N, et al. (1989) Methotrexate, vinblastine, doxorubicin and cisplatin for advanced transitional cell carcinoma of the urothelium: efficacy and patterns of response and relapse. Cancer 64:2448-2458
    • (1989) Cancer , vol.64 , pp. 2448-2458
    • Sternberg, C.N.1    Yagoda, A.2    Scher, H.I.3    Watson, R.C.4    Geller, N.5    Herr, H.W.6    Morse, M.J.7    Sogani, P.C.8    Vaughan, E.D.9    Bander, N.10
  • 36
    • 0028877082 scopus 로고
    • Paclitaxel, cisplatin and methotrexate combination therapy is active in the treatment of refractory urothelial malignancies
    • Tu S, Hossan E, Amato R, Kilbourn R, Logothetis CJ (1995) Paclitaxel, cisplatin and methotrexate combination therapy is active in the treatment of refractory urothelial malignancies. JUrol 154:1719-1722
    • (1995) JUrol , vol.154 , pp. 1719-1722
    • Tu, S.1    Hossan, E.2    Amato, R.3    Kilbourn, R.4    Logothetis, C.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.